Here, Ross Turnbull, Director of Business Development at ASIC design and supply specialist Swindon Silicon Systems, explains why the silicon behind those sensors matters as much as the investment itself.
Through the Life Sciences Innovative Manufacturing Fund, the government is supporting projects that expand the production of medicines and vaccines.
The fund will help to unlock more than £600 million of private investment in UK life sciences manufacturing this year.
As Health and Social Care Secretary James Murray put it, the plan has “brought in £3 billion to speed up access to innovative treatments” during that same period.
In addition, the £520 million capital grants scheme, introduced as part of the Life Sciences Sector Plan, is intended to strengthen UK manufacturing capability, with recent funding supporting projects including a near-patient biomanufacturing facility to produce medicines and vaccines for clinical trials.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
